SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
amphotericin b
Journals
5
1
Carbohydrate polymers
2
artificial cells, nanomedicine, and biotechnology
3
BMC infectious diseases
4
Journal of microbiology and biotechnology
5
ACS infectious diseases
Research Groups
0
No Research Group Connected
Bibliographies
35
1
Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform.
2
Preliminary investigation of novel tetra-tailed macrocycle amphiphile based nano-vesicles for amphotericin B improved oral pharmacokinetics.
3
Fabrication of lecithin-gum tragacanth muco-adhesive hybrid nano-carrier system for in-vivo performance of Amphotericin B.
4
feed back of the parents and / or relatives witnessing a squint surgery of their ward in the operation theater
5
disseminated systemic mucormycosis. (a case report).
6
clinical manifestations and management of cryptococcal infection.
7
successful treatment of pulmonary mucormycosis in a child with aplastic anemia
8
comparación de métodos de microdilución clsi m27-a2 y eucast en aislamientos de candida spp. en pacientes con cáncer clsi microdilution m27-a2 and eucast method comparison for candida spp. in patients with cancer
9
solubilization behavior of polyene antibiotics in nanomicellar system: insights from molecular dynamics simulation of the amphotericin b and nystatin interactions with polysorbate 80
10
nasopalpebral lipoma coloboma syndrome
11
effect of itraconazole on the cornea in a murine suture model and penetrating keratoplasty model
12
efficacy of oral amphotericin b for refractory atopic dermatitis with specific ige to candida albicans and food allergens in sera
13
effect of types of solid lipids on the physicochemical properties and self-aggregation of amphotericin b loaded nanostructured lipid carriers (nlcs)
14
Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases.
15
Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis
16
Bacillomycin D and its combination with amphotericin B: Promising antifungal compounds with powerful antibiofilm activity and wound-healing potency
17
Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada
18
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
19
Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada
20
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
21
Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar.
22
Oleic Acid Coated Silver Nanoparticles Showed Better Amoebicidal Effects against than Amphotericin B.
23
Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B.
24
Synergistic antifungal interactions of amphotericin B with 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol.
25
[Effect of amphotericin B on the diuretic action of diacarb and various indicators of water-salt metabolism in healthy and tumor-bearing animals].
26
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
27
anti-transferrin receptor-modified amphotericin b-loaded pla–peg nanoparticles cure candidal meningitis and reduce drug toxicity
28
nanodisk containing super aggregated amphotericin b: a high therapeutic index antifungal formulation with enhanced potency
29
intralipid efficacy in decreasing amphotericin b associated nephrotoxicity
30
evaluation of mucorales dna load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin b
31
properties of an oral nanoformulation of a molecularly dispersed amphotericin b comprising a composite matrix of theobroma oil and bee’s wax
32
delayed results of treatment of paracoccidioidomycosis with amphotericin b plus sulfamides versus amphotericin b alone
33
aspectos clínicos e sorológicos de 47 pacientes com paracoccidioidomicose tratados pela anfotericina b clinical and serologic features of 47 patients with paracoccidioidomycosis treated by amphotericin b
34
post-marketing study to assess the safety, tolerability and effectiveness of fungisometm: an indian liposomal amphotericin b preparation
35
Efficacy of Liposomal Amphotericin B Combined with Gamma Interferon or Granulocyte-Macrophage Colony-Stimulating Factor for Treatment of Systemic Zygomycosis in Mice